Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examination of the Multiple Genetic and Molecular Targets as Therapeutic Options for Patients With Ependymoma Treated by the Phase II Children's Oncology Group Study ACNS0121

NCT01407744 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01407744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01407744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examination of the Multiple Genetic and Molecular Targets as Therapeutic Options for Patients With Ependymoma Treated by the Phase II Children's Oncology Group Study ACNS0121
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
April 30, 2013
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood infratentorial ependymoma, childhood supratentorial ependymoma, newly diagnosed childhood ependymoma